Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other Accumulated Expenses (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Other Accumulated Expenses for 4 consecutive years, with $24138.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 59.79% to $24138.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24138.0 through Dec 2025, down 59.79% year-over-year, with the annual reading at $24138.0 for FY2025, 59.79% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $24138.0 at bioAffinity Technologies, down from $28658.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $112590.0 in Q2 2025, with the low at $1751.0 in Q2 2024.
  • Average Other Accumulated Expenses over 4 years is $28644.8, with a median of $19498.0 recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses plummeted 64.98% in 2024, then soared 6330.04% in 2025.
  • Over 4 years, Other Accumulated Expenses stood at $5852.0 in 2022, then surged by 233.19% to $19498.0 in 2023, then skyrocketed by 207.9% to $60035.0 in 2024, then tumbled by 59.79% to $24138.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $24138.0, $28658.0, and $112590.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.